Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schallenberg

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Cancers|January 11, 2022
Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal AdenocarcinomaFiona Speichinger, Mihnea P Dragomir, Simon Schallenberg, et al.
Oncoimmunology|July 9, 2026
Immune evasion in locally advanced mismatch repair-deficient microsatellite instability-high colorectal cancer: Reduced T-cell infiltration and upregulation of epithelial IDO1 expressionSabina Niyazova, Christine Sers, Hendrik Bläker, et al.
Ebiomedicine|June 22, 2023
DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumoursMihnea P Dragomir, Teodor G Calina, Eilís Perez, et al.
Pathology, Research and Practice|April 11, 2025
Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancerBenedikt Ebner, Lennert Eismann, Julian Hermans, et al.
Medcomm|September 10, 2025
AI Algorithm for Lung Adenocarcinoma Pattern Quantification (PATQUANT): International Validation and Advanced Risk Stratification Superior to Conventional GradingYuan Wang, Kris Lami, Waleed Ahmad, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world studyGabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
The Lancet. Digital Health|April 26, 2023
Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation studyYuri Tolkach, Lisa Marie Wolgast, Alexander Damanakis, et al.
Journal of Personalized Medicine|March 26, 2025
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients-A Multicenter AnalysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 27, 2023
Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Cancers|January 11, 2022
Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal AdenocarcinomaFiona Speichinger, Mihnea P Dragomir, Simon Schallenberg, et al.
Oncoimmunology|July 9, 2026
Immune evasion in locally advanced mismatch repair-deficient microsatellite instability-high colorectal cancer: Reduced T-cell infiltration and upregulation of epithelial IDO1 expressionSabina Niyazova, Christine Sers, Hendrik Bläker, et al.
Ebiomedicine|June 22, 2023
DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumoursMihnea P Dragomir, Teodor G Calina, Eilís Perez, et al.
Pathology, Research and Practice|April 11, 2025
Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancerBenedikt Ebner, Lennert Eismann, Julian Hermans, et al.
Medcomm|September 10, 2025
AI Algorithm for Lung Adenocarcinoma Pattern Quantification (PATQUANT): International Validation and Advanced Risk Stratification Superior to Conventional GradingYuan Wang, Kris Lami, Waleed Ahmad, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world studyGabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
The Lancet. Digital Health|April 26, 2023
Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation studyYuri Tolkach, Lisa Marie Wolgast, Alexander Damanakis, et al.
Journal of Personalized Medicine|March 26, 2025
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients-A Multicenter AnalysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 27, 2023
Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
Pageof 8